ABPI sets up links to clinical trials databases
July 7, 2005Sales and Marketing
Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …
Pfizer pulls out of Daxas collaboration
July 7, 2005Sales and Marketing Daxas, Nycomed, Pfizer
Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …
One Europe for pharma marketers?
July 6, 2005Sales and Marketing
Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …
No more Alton Towers? UK pharma downsizes its hospitality
July 6, 2005Sales and Marketing
UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …
Lilly buys rights to novel diabetes drug
July 6, 2005Research and Development, Sales and Marketing
Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
Antidepressants come under FDA review again
July 4, 2005Sales and Marketing
The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …
GSK excited about new vaccines
July 4, 2005Sales and Marketing
GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …
Doctors have no time to mentor nurse prescribers
June 30, 2005Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …
The golden rules of PR
June 29, 2005Medical Communications
In light of the enormous potential brand benefits of pharma PR, the question should not be 'Shall we invest in …
Humira receives two European recommendations
June 29, 2005Sales and Marketing
Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …
All aboard the health train
June 29, 2005Medical Communications
Making friends and influencing people is an area, it's widely agreed, where big pharma could do better. Few companies, however, …
New products key to Schering growth
June 29, 2005Sales and Marketing
Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …
FDA approves new HIV drug Aptivus
June 29, 2005Sales and Marketing
Boehringer Ingelheim's new HIV drug Aptivus has been granted accelerated approval by the FDA. Aptivus (tipranavir) has been approved for …
GSK forms hypertension alliance
June 29, 2005Sales and Marketing
GlaxoSmithKline has formed a strategic alliance with an emerging pharma company to develop and commercialise novel compounds to treat hypertension …
FDA approves first ‘ethnic’ heart drug
June 29, 2005Research and Development, Sales and Marketing
The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …
Woolley Pau wins Chiron campaign
June 29, 2005Medical Communications
Woolley Pau has been appointed by Chiron Biopharma Europe to work on a pan-European launch campaign, following a four-way pitch.A …
Latest content
FibroFind appoints Lee Borthwick as CEO
